EVAN MULAMBA: Open Payments
NPI 1700539236 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$137 in 6 payments from 4 companies in 2025. Trend: 2023 $300 · 2024 $130 · 2025 $137
Food & beverage: $137
| Company | Payments | Amount |
|---|---|---|
| MILLICENT US INC | 3 | $56 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $31 |
| Astellas Pharma US Inc | 1 | $30 |
| Evofem Biosciences, Inc. | 1 | $19 |
Products named: FEMLYV, Veozah, Phexxi.
Industry payments across TX — which companies pay providers there.
